Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study on Eltrombopag in Hypocellular Myelodysplastic Neoplasms

NCT07825207 is registered in ClinicalTrials.gov with Fondazione Italiana Sindromi Mielodisplastiche-ETS as lead sponsor.

NCT NCT07825207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07825207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study on Eltrombopag in Hypocellular Myelodysplastic Neoplasms
Lead sponsor
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Phase
Observational
Overall status
Active, not recruiting
Start date
May 1, 2026
Completion date
July 31, 2027
Enrollment
100 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic neoplasm, myelodysplastic syndrome